Skip to main content

ORIGINAL RESEARCH article

Front. Neurosci., 28 June 2016
Sec. Neuropharmacology
Volume 10 - 2016 | https://doi.org/10.3389/fnins.2016.00303

Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma

Updated

A correction has been applied to this article in:

  1. Retraction: Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma

    1. Read correction
\r\nHua Liu&#x;Hua Liu1†Zhengxiang Luo&#x;Zhengxiang Luo2†Zhongkun Liu&#x;Zhongkun Liu3†Jian YangJian Yang1Shifeng Kan*Shifeng Kan4*
  • 1Department of Neurosurgery, The First People's Hospital of Kunshan Affiliated with Jiangsu University, Suzhou, China
  • 2Department of Neurosurgery, The Affiliated Brain Hospital, Nanjing Medical University, Nanjing, China
  • 3Department of Neurosurgery, The People's Hospital of AnQiu City, Weifang, China
  • 4Department of Rehabilitation Medicine, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Liu H, Luo Z, Liu Z, Yang J and Kan S (2016) Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma. Front. Neurosci. 10:303. doi: 10.3389/fnins.2016.00303

Received: 15 November 2015; Accepted: 15 June 2016;
Published: 28 June 2016; Retracted: 07 October 2016.

Edited by:

Arjan Blokland, Maastricht University, Netherlands

Reviewed by:

Andrew Ducruet, University of Pittsburgh, USA
William Jacob Mack, University of Southern California, USA

†These authors have contributed equally to this work.

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.